Literature DB >> 12629166

Dopamine modulation of perisomatic and peridendritic inhibition in prefrontal cortex.

Wen-Jun Gao1, Yun Wang, Patricia S Goldman-Rakic.   

Abstract

The computations underlying cognitive functions are performed by a diversity of interactions between interneurons and pyramidal neurons that are subject to modulatory influences. Here we have used paired whole-cell recording to study the influence of dopamine on local inhibitory circuits involving fast-spiking (FS) and non-FS cells, respectively. We found that dopamine depressed inhibitory transmission between FS interneurons and pyramidal neurons but enhanced inhibition between non-FS interneurons and pyramidal cells. FS inhibitory transmission exhibited properties associated with presynaptic action at D(1) receptors that were not evident in non-FS inhibitory connections. In addition, FS and non-FS interneurons differed morphologically, forming contacts on the perisomatic and peridendritic domains, respectively, of their pyramidal cell targets. These findings provide evidence for both a dual mode of inhibition in prefrontal circuitry and circuit-dependent modulation by dopamine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12629166      PMCID: PMC6741986     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  47 in total

1.  Division of labor among distinct subtypes of inhibitory neurons in a cortical microcircuit of working memory.

Authors:  X-J Wang; J Tegnér; C Constantinidis; P S Goldman-Rakic
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-23       Impact factor: 11.205

2.  Dopaminergic modulation of short-term synaptic plasticity at striatal inhibitory synapses.

Authors:  Fatuel Tecuapetla; Luis Carrillo-Reid; José Bargas; Elvira Galarraga
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-01       Impact factor: 11.205

3.  Genetic modulation of GABA levels in the anterior cingulate cortex by GAD1 and COMT.

Authors:  Stefano Marenco; Antonina A Savostyanova; Jan Willem van der Veen; Matthew Geramita; Alexa Stern; Alan S Barnett; Bhaskar Kolachana; Eugenia Radulescu; Fengyu Zhang; Joseph H Callicott; Richard E Straub; Jun Shen; Daniel R Weinberger
Journal:  Neuropsychopharmacology       Date:  2010-03-31       Impact factor: 7.853

4.  Perisomatic GABA release and thalamocortical integration onto neocortical excitatory cells are regulated by neuromodulators.

Authors:  Illya Kruglikov; Bernardo Rudy
Journal:  Neuron       Date:  2008-06-26       Impact factor: 17.173

5.  Dissociable dopaminergic control of saccadic target selection and its implications for reward modulation.

Authors:  Alireza Soltani; Behrad Noudoost; Tirin Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

6.  Brief dopaminergic stimulations produce transient physiological changes in prefrontal pyramidal neurons.

Authors:  Anna R Moore; Wen-Liang Zhou; Evgeniy S Potapenko; Eun-Ji Kim; Srdjan D Antic
Journal:  Brain Res       Date:  2010-11-06       Impact factor: 3.252

7.  Olanzapine antipsychotic treatment of adolescent rats causes long term changes in glutamate and GABA levels in the nucleus accumbens.

Authors:  Su Xu; Rao P Gullapalli; Douglas O Frost
Journal:  Schizophr Res       Date:  2014-12-05       Impact factor: 4.939

8.  Repeated cocaine exposure increases fast-spiking interneuron excitability in the rat medial prefrontal cortex.

Authors:  Emilie Campanac; Dax A Hoffman
Journal:  J Neurophysiol       Date:  2013-03-13       Impact factor: 2.714

9.  Temporal dynamics of parvalbumin-expressing axo-axonic and basket cells in the rat medial prefrontal cortex in vivo.

Authors:  Lema Massi; Michael Lagler; Katja Hartwich; Zsolt Borhegyi; Peter Somogyi; Thomas Klausberger
Journal:  J Neurosci       Date:  2012-11-14       Impact factor: 6.167

10.  Cell type-specific development of NMDA receptors in the interneurons of rat prefrontal cortex.

Authors:  Huai-Xing Wang; Wen-Jun Gao
Journal:  Neuropsychopharmacology       Date:  2009-02-25       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.